| Write You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Real Estate > Mortgage Refinance > What Are Bridging Loans Used For? |
|
Write You - What Are Bridging Loans Used For?
The bridging sector is extremely competitive, which is good news for
borrowers. The days when bridging loans were used solely for the
purposes of purchasing a new house prior to the sale of the old one
are long gone. With th According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product e bridging market believed to be worth ?2.5
billion and increasing by 25% each year. We now live in a world
where bridging loans can be arranged for just about any purpose,
residential or commercial. For a long time many br ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in dging finance lenders viewed the market
as a lucrative opportunity rather than focusing on the long term
possibilities. As well as an absence of innovation, a lack of clarity
and tortuous small print are the most common crit lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. cisms levelled at
the bridging industry. In the past this left many would-be
customers disillusioned and prepared to sacrifice an opportunity
rather than risk paying extortionate fees on bridging loans.
However times are c here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe anging and the bridging finance market is
rapidly re-branding itself as a cost effective tool to help property
developers and investors seize opportunities. Winning the trust and confidence of potential customers is somethi d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro g that new entrants to the bridging finance market have
spent a lot of time and money on. A new company launching will
have invested heavily in PR and advertising to the broker
community to establish a clean image. With thi ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc s increased competition the range of choice for borrowers
is constantly growing. It is now possible for an individual or
business with a bad credit history to pass the credit check stage
and arrange a bridging loan at compet easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi tive rates and terms.
Some of the more common uses of bridging finance include: Auctions: When purchasing property at auction the borrower usually has a deadline of 28 days to complete the process. Altho nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically gh it is not
uncommon for borrows to be told that it is possible to complete
purchase using conventional finance in practice the funding is
rarely available in time. Having paid a 10% deposit it is vital that
completion t and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ kes place within the deadline. This is where bridging
loans are most useful, once the valuation has been received legal
completion can often take place within a few days. Buying Property at Undervalue: ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi pproaching a mainstream lender with a proposal to purchase a
property at under value is pointless as they will only consider the
purchase price. However bridging loans can be raised against the
value of the property and not ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a the purchase price. This means that
theoretically it is possible to purchase a property at discount
without putting any money into the deal. Debt Relief: Business people often get into financial diffic dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod lties due to cash-flow
problems. These can be a result of trading problems or even
unexpected tax demands, where there is equity in a freehold
property bridging loans are an ideal solution. Currently there is no Code of Pr cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ctice, or indeed any self-
regulating body to govern the activities of bridging lenders,
although there have been several attempts to form one. The
Council of Mortgage Lenders (CML) will accept bridging finance
lenders as tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen embers, as will the National Association of Commercial
Finance Brokers (NACFB) but neither organisation is geared to
examine the specifics of bridging loans. Where the loan is required
to assist with the purchase of a famil t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel home the Financial Services
Authority (FSA) have very strict controls over who can lend money
and under what terms. One of the things to look out for with bridging loans is the practise of charging penalty interest if any ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust payments are late. The penalty
rate can more than double the original rate, so care should be
taken to ensure that late payments are avoided. Again, increased
competition has forced lenders to reconsider this practice, but i y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
still exists. Borrowers should also be aware that many bridging lenders will have a minimum loan term, usually this will be between 1 to 3 months. It is worth being aware of the exit or redemption fees as some lenders wi . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de l try to increase their profits by charging excessive
amounts. It is also worth keeping an eye on the legal and survey
fees as these can be an opportunity for lenders to try to make
more money. Most bridging lenders are now elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip well organised, customer focused
organisations, the on-going threat of increased regulation has
seen the death of some of the unsavoury business practices which
means that bridging loans should continue to be a valuable tool tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Debt Management-Get Rid Of Previous Debts More Trucks On the Road Than Ever!
|